Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY20 results · Apr–Jun 2019
Dr. Lal Path Labs reported revenue from operations of ₹335.20 crore (up 14.7% from Q1 FY19) and net profit of ₹59.10 crore (up 18.9% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 335.20 | 292.30 | +14.7% | 301.10 | +11.3% |
| Other income | 14.40 | 9.40 | +53.2% | 13.50 | +6.7% |
| Total income | 349.60 | 301.70 | +15.9% | 314.60 | +11.1% |
| Profit before tax | 89.40 | 75.40 | +18.6% | 69.20 | +29.2% |
| Net profit for the period | 59.10 | 49.70 | +18.9% | 47.40 | +24.7% |
| Attributable to shareholders of the company | 58.80 | 49.40 | +19.0% | 47.10 | +24.8% |
| EPS, basic (₹) | 7.14 | 6.00 | +19.0% | 5.72 | +24.8% |
| Net margin (%) | 17.6 | 17.0 | 15.7 |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 324.50 | 282.90 | +14.7% | 292.00 | +11.1% |
| Other income | 14.10 | 10.90 | +29.4% | 13.00 | +8.5% |
| Total income | 338.60 | 293.80 | +15.2% | 305.00 | +11.0% |
| Profit before tax | 86.70 | 74.90 | +15.8% | 67.10 | +29.2% |
| Net profit for the period | 57.30 | 49.80 | +15.1% | 46.00 | +24.6% |
| EPS, basic (₹) | 6.95 | 6.05 | +14.9% | 5.59 | +24.3% |
| Net margin (%) | 17.7 | 17.6 | 15.8 |
Consolidated
- Filed with BSE
- 13 Aug 2019, 16:56 IST
- Board meeting
- 13 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2019, 16:56 IST
- Board meeting
- 13 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE